Dr. David Schneider
Founder and CEO @ Qualifyze
Dr. David Schneider is a seed investor at Qualifyze focused on B2C and Pet. Dr. David Schneider is the Founder and CEO at Qualifyze.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Dr. David Schneider invests in
Stages Dr. David Schneider invests in
Countries Dr. David Schneider invests in
Investment Focus
Industry
- B2C 1 (50%)
- Pet 1 (50%)
- Medical 1 (50%)
- Health Care 1 (50%)
- Medical Device 1 (50%)
Stage
- Seed 1 (50%)
- Pre-Seed 1 (50%)
Country
- Austria 1 (50%)
- Germany 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Our vision is to make high-quality health products accessible for everyone. We will achieve this by enabling creators of health products to build and operate high-quality products with 10x efficiency. We are putting our initial focus on automating compliance and regulatory tasks for medical device manufacturers. Our product offering includesAI-enabled automation of major parts of the data collection, aggregation, evaluation, and reporting for post-market surveillance activities. | $6.7M / Seed / Sep 30, 2024 | |
|
|
HEY HOLY is redefining dog nutrition with the world’s first breed-specific dog food sold in a subscription. We believe every dog deserves food tailored to their unique health needs – because a German Shepherd isn’t a Chihuahua.Backed by science and crafted with only high-quality ingredients, HEY HOLY supports better digestion, fewer intolerances,and healthier, longer lives for dogs. Thousands of owners have already made the switch, choosing HEY HOLY to give their dogs personalized care and optimal health outcomes. | $1.1M / Pre-Seed / Dec 20, 2022 |
Co-Investors
About Qualifyze
Qualifyze (former ChemSquare) was founded out of the Technical University of Darmstadt in September 2017. Today, we are based in Frankfurt am Main, the heart of Germany’s pharmaceutical cluster, where the leading life science companies are based. Our team consists of 16 people with diverse backgrounds and areas of expertise in business,engineering, and technology as well as several strategic partners from the pharma, food and cosmetics industry.
Qualifyze Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Dr. David Schneider
Founder and CEO
|
|||
|
David Schneider
Founder and CEO
|
|||
|
Florian Hildebrand
Co-Founder, Managing Partner & CEO
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Dr. David Schneider invest in?
Dr. David Schneider invests primarily in B2C, Pet and Medical startups, most often at Seed and Pre-Seed stage. Most of the 2 investments tracked by Shizune back companies in Austria. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Dr. David Schneider last invest?
The most recent investment recorded for Dr. David Schneider closed in Sep 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!